{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:36:11Z","timestamp":1784054171307,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.forsciint.2025.112479","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T15:59:16Z","timestamp":1745337556000},"page":"112479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A new synthetic opioid threat: A comprehensive review on MT-45"],"prefix":"10.1016","volume":"371","author":[{"given":"Sena Nur","family":"Kadem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8250-7520","authenticated-orcid":false,"given":"Zeynep","family":"Turkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2025.112479_bib1","unstructured":"UNODCThe challenge of new psychoactive substances: a report from the Global SMART Programme, 2013."},{"key":"10.1016\/j.forsciint.2025.112479_bib2","unstructured":"EMCDDA, EMCDDA\u2013Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4- (1,2-diphenylethyl)piperazine (\u2018MT-45\u2019), Lisbon, 2014."},{"key":"10.1016\/j.forsciint.2025.112479_bib3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/15563650.2014.943908","article-title":"MT-45, a new psychoactive substance associated with hearing loss and unconsciousness","volume":"52","author":"Helander","year":"2014","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/aip.aip_57_19","article-title":"New psychoactive substances: An emerging epidemic","volume":"3","author":"Kadam","year":"2019","journal-title":"Ann. Indian Psychiatry"},{"key":"10.1016\/j.forsciint.2025.112479_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC-MS-MS and its identification in a drug-related death","volume":"40","author":"Papsun","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib6","doi-asserted-by":"crossref","unstructured":"B.K. Sharma, G. Chandra, V.P. MishraComparitive analysis and implication of UAV and AI in forensic investigations. In: Proceedings - 2019 Amity International Conference on Artificial Intelligence, AICAI 2019, 2019). pp. 824\u2013827. https:\/\/doi.org\/10.1109\/AICAI.2019.8701407.","DOI":"10.1109\/AICAI.2019.8701407"},{"key":"10.1016\/j.forsciint.2025.112479_bib7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1360-0443.2010.02934.x","article-title":"Legal highs and the challenges for policy makers","volume":"105","author":"Winstock","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2025.112479_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMp1505328","article-title":"SyntHetic Cannabinoid\u2013related Illnesses and Deaths","volume":"373","author":"Trecki","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.forsciint.2025.112479_bib9","unstructured":"United Nations Office on Drugs and Crime. Early warning advisory on new psychoactive substances, 2018.."},{"key":"10.1016\/j.forsciint.2025.112479_bib10","unstructured":"UNODC,UNODC Early Warning Advisory on NPS - Summary dashboard, UNODC Early Warning Advisory (2024). https:\/\/www.unodc.org\/LSS\/Page\/NPS\/DataVisualisations (accessed October 26, 2024)."},{"key":"10.1016\/j.forsciint.2025.112479_bib11","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6105.1000287","article-title":"The quest for well-being and pleasure: experiences of the novel synthetic opioids AH-7921 and MT-45, as reported by anonymous users online","volume":"7","author":"Kjellgren","year":"2016","journal-title":"J. Addict. Res Ther."},{"key":"10.1016\/j.forsciint.2025.112479_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/15563650.2014.983239","article-title":"Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45","volume":"53","author":"Siddiqi","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib13","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, European drug report 2022:Trends and developments, Luxembourg, 2022. https:\/\/doi.org\/10.2810\/715044."},{"key":"10.1016\/j.forsciint.2025.112479_bib14","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic, Luxembourg., 2020. https:\/\/doi.org\/10.2810\/845598."},{"key":"10.1016\/j.forsciint.2025.112479_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.forsciint.2025.112479_bib16","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s00204-020-02855-7","article-title":"In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances","volume":"94","author":"Vandeputte","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/20961790.2019.1588933","article-title":"Novel synthetic opioids\u2013toxicological aspects and analysis","volume":"4","author":"Tabarra","year":"2019","journal-title":"Forensic Sci. Res."},{"key":"10.1016\/j.forsciint.2025.112479_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2017.00110","article-title":"An expanding world of novel psychoactive substances: opioids","volume":"8","author":"Zawilska","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.forsciint.2025.112479_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","article-title":"DARK classics in chemical neuroscience: etonitazene and related benzimidazoles","volume":"12","author":"Ujv\u00e1ry","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.forsciint.2025.112479_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAF.0000000000000787","article-title":"Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances","volume":"43","author":"Papsun","year":"2022","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.forsciint.2025.112479_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111775","article-title":"Non-fentanyl new synthetic opioids \u2013 an update","volume":"349","author":"Zawilska","year":"2023","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2025.112479_bib22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1021\/jm00246a014","article-title":"Studies on 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives and their analgesic activities. 1","volume":"18","author":"Natsuka","year":"1975","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.forsciint.2025.112479_bib23","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/jm00393a017","article-title":"Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity","volume":"30","author":"Natsuka","year":"1987","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.forsciint.2025.112479_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuropharm.2017.08.016","article-title":"Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace","volume":"134","author":"Baumann","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.forsciint.2025.112479_bib25","unstructured":"Bluelight, M.T.-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), 2016. \u3008https:\/\/www.bluelight.org\/community\/threads\/mt-45-1-cyclohexyl-4-1-2-diphenylethyl-piperazine.640564\/\u3009 (accessed September 27, 2024)."},{"key":"10.1016\/j.forsciint.2025.112479_bib26","unstructured":"Shroomery, MT-45, 2014. \u3008www.shroomery.org\/forums\/showflat.php\/Number\/18265612\u3009 (accessed September 27, 2024)."},{"key":"10.1016\/j.forsciint.2025.112479_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11419-013-0194-5","volume":"32","author":"Uchiyama","year":"2014","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/jm00210a017","article-title":"1-Cycloalkyl-4-(1,2-diphenylethyl) piperazines","volume":"21","author":"Natsuka","year":"1978","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.forsciint.2025.112479_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0024-3205(83)90534-9","article-title":"1,2-diphenylethyl) piperazines as potent opiate-like analgesics; The unusual relationships between stereoselectivity and affinity to opioid receptor","volume":"33","author":"Nozaki","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.forsciint.2025.112479_bib30","unstructured":"H. Nishimura, H. Uno, K. Natsuka, N. Shimokawa, M. Shimizu1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives and compositions containing the same, US Patent 4,080,453, 1978.."},{"key":"10.1016\/j.forsciint.2025.112479_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/ja01157a097","article-title":"Diphenylethylamines. I. The preparation of tertiary amines by the Grignard reaction","volume":"72","author":"Goodson","year":"1950","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.forsciint.2025.112479_bib32","unstructured":"EMCDDA, Report on the risk assessment of MT-45 in the framework of the Council Decision on new psychoactive substances, 2015."},{"key":"10.1016\/j.forsciint.2025.112479_bib33","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1111\/bph.15064","article-title":"Activation of \u03bc-opioid receptors by MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) and its fluorinated derivatives","volume":"177","author":"Baptista-Hon","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2025.112479_bib34","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.forsciint.2017.04.003","article-title":"Two fatalities associated with synthetic opioids: AH-7921 and MT-45","volume":"277","author":"Fels","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2025.112479_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/bjd.15174","article-title":"Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45","volume":"176","author":"Helander","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.forsciint.2025.112479_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11419-018-0413-1","article-title":"Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users","volume":"36","author":"McKenzie","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/dta.2390","article-title":"Direct detection of the psychoactive substance MT-45 in human tissue samples by probe electrospray ionization-tandem mass spectrometry","volume":"10","author":"Usui","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2025.112479_bib38","unstructured":"US Immigration and Custom Enforcement, HSI seizes web sites selling potentially deadly illegal narcotics., 2014."},{"key":"10.1016\/j.forsciint.2025.112479_bib39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/jat\/bky053","article-title":"Quantitative analysis of novel synthetic opioids, morphine and buprenorphine in oral fluid by LC\u2013MS-MS","volume":"42","author":"Truver","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib40","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/dta.2393","article-title":"Analysis of fentanyl analogs and novel synthetic opioids in blood, serum\/plasma, and urine in forensic casework","volume":"10","author":"Moody","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2025.112479_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11419-018-0458-1","article-title":"Quantification of seven novel synthetic opioids in blood using LC\u2013MS\/MS","volume":"37","author":"Lowry","year":"2019","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2025.112479_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.vibspec.2020.103176","article-title":"Raman spectroscopy and gas chromatography with flame ionization detection as analysis tools in stability tests of selected synthetic psychoactive substances: 5-IT, MT-45 and 4-CMC","volume":"111","author":"Fr\u0105czak","year":"2020","journal-title":"Vib. Spectrosc."},{"key":"10.1016\/j.forsciint.2025.112479_bib43","unstructured":"Circular 003\/2015: a change to the misuse of drugs Act 1971: control of MT-45 and 4,4\u2019-DMAR, 2015. https:\/\/www.gov.uk\/government\/publications\/circular-0032015-a-change-to-the-misuse-of-drugs-act-1971-control-of-mt-45-and-44-dmar (accessed October 27, 2024).."},{"key":"10.1016\/j.forsciint.2025.112479_bib44","unstructured":"UNODC, Inclusion of MT-45 in schedule I of the single convention on narcotic drugs of 1961 as amended by the 1972 Protocol, 2016."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T18:38:26Z","timestamp":1747852706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073825001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S0379073825001173"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112479","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new synthetic opioid threat: A comprehensive review on MT-45","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112479"}}